Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1791029
Max Phase: Preclinical
Molecular Formula: C9H12N6O3
Molecular Weight: 252.23
Molecule Type: Small molecule
Associated Items:
ID: ALA1791029
Max Phase: Preclinical
Molecular Formula: C9H12N6O3
Molecular Weight: 252.23
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: [N-]=[N+]=N[C@H]1C[C@H](n2ccc(N)nc2=O)O[C@@H]1CO
Standard InChI: InChI=1S/C9H12N6O3/c10-7-1-2-15(9(17)12-7)8-3-5(13-14-11)6(4-16)18-8/h1-2,5-6,8,16H,3-4H2,(H2,10,12,17)/t5-,6+,8+/m0/s1
Standard InChI Key: YIEFKLOVIROQIL-SHYZEUOFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 252.23 | Molecular Weight (Monoisotopic): 252.0971 | AlogP: -0.22 | #Rotatable Bonds: 3 |
Polar Surface Area: 139.13 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: -1.08 | CX LogD: -1.19 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.43 | Np Likeness Score: 1.30 |
1. Lin TS, Gao YS, Mancini WR.. (1983) Synthesis and biological activity of various 3'-azido and 3'-amino analogues of 5-substituted pyrimidine deoxyribonucleosides., 26 (12): [PMID:6644738] [10.1021/jm00366a006] |
2. Van Aerschot A, Everaert D, Balzarini J, Augustyns K, Jie L, Janssen G, Peeters O, Blaton N, De Ranter C, De Clercq E.. (1990) Synthesis and anti-HIV evaluation of 2',3'-dideoxyribo-5-chloropyrimidine analogues: reduced toxicity of 5-chlorinated 2',3'-dideoxynucleosides., 33 (6): [PMID:2342078] [10.1021/jm00168a046] |
3. Herdewijn P, Balzarini J, Baba M, Pauwels R, Van Aerschot A, Janssen G, De Clercq E.. (1988) Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides., 31 (10): [PMID:3172142] [10.1021/jm00118a033] |
4. Lin TS, Guo JY, Schinazi RF, Chu CK, Xiang JN, Prusoff WH.. (1988) Synthesis and antiviral activity of various 3'-azido analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1, HTLV-III/LAV)., 31 (2): [PMID:3339606] [10.1021/jm00397a011] |
5. Lin TS, Chen MS, McLaren C, Gao YS, Ghazzouli I, Prusoff WH.. (1987) Synthesis and antiviral activity of various 3'-azido, 3'-amino, 2',3'-unsaturated, and 2',3'-dideoxy analogues of pyrimidine deoxyribonucleosides against retroviruses., 30 (2): [PMID:3643284] [10.1021/jm00385a033] |
6. Lin TS, Mancini WR.. (1983) Synthesis and antineoplastic activity of 3'-azido and 3'-amino analogues of pyrimidine deoxyribonucleoside., 26 (4): [PMID:6834387] [10.1021/jm00358a016] |
7. Chu CK, Schinazi RF, Ahn MK, Ullas GV, Gu ZP.. (1989) Structure-activity relationships of pyrimidine nucleosides as antiviral agents for human immunodeficiency virus type 1 in peripheral blood mononuclear cells., 32 (3): [PMID:2918508] [10.1021/jm00123a018] |
Source(1):